BackOrphazyme A/S Overview

Orphazyme A/S Profit Margin

Orphazyme A/S (ORPHA.CO) has a profit margin of -485.57%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

1019.00%

As of Jun 2026

Annual Profit Margin (TTM)

-485.57%

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Orphazyme A/S (ORPHA.CO) FAQ

The latest profit margin for ORPHA.CO is -485.57% as of June 2026. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Orphazyme A/S's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ORPHA.CO currently prints -485.57% for profit margin, while the sector average sits near 17.63%. That is roughly 2854.5% below the sector mean. Large gaps often invite a closer look at Orphazyme A/S's growth, margins, and balance sheet.

Profit Margin shows how effectively Orphazyme A/S converts resources into returns. At -485.57%, ORPHA.CO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ORPHA.CO's profit margin (-485.57%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Orphazyme A/S's profit margin against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.